ASOP Statement – AI Principles
January 15, 2025
ASOP Global Releases Principles for the Safe Use of Artificial Intelligence.
News Releases
Statement on USTR 2024 Notorious Markets Report
January 13, 2025
USTR 2024 Notorious Markets Report Includes ASOP Global Recommendations and Data
ASOP Statement – Tech Industry Accountability
December 20, 2024
ASOP Global Urges Tech Industry Accountability Following Reported Talks on Combating Illegal Online Drug Sales
ASOP Global Welcomes New Member Rx Outreach
June 18, 2024
ASOP Global welcomes Rx Outreach, the largest nonprofit online pharmacy in the United States.
ASOP EU – New Report “Unlock potential of online prescription medicines in Europe”
February 8, 2024
Large-scale evidence on patients, carers and pharmacy owners asking for a greater choice that improves access to medicines and health outcomes.
ASOP Global Statement on FDA Approval of Florida Drug Importation Plan
January 5, 2024
ASOP Global raises concerns on Florida’s Section 804 Importation Program approval.
ASOP Statement on Commerce and Technology Hearing
December 20, 2023
ASOP Global urges Congress to remain steadfast in its commitment to expanding nationwide broadband access while ensuring the safety of users in the digital space is paramount.
ASOP Statement for the Congressional Record
December 20, 2023
Statement for the Congressional Record in support of NTIA Programming to combat illegal online drug sales.
National Consumer Survey:
December 6, 2023
Newly released survey data commissioned by the Alliance for Safe Online Pharmacies (ASOP Global) Foundation shows more Americans are buying prescription medication online than ever. That number is rising, driven by cost and convenience, accelerated by the pandemic, and fueled by drug shortages and changes in access. However, most consumers make dangerous, false assumptions about the safety, oversight, and compliance of online drug sellers and the serious health risks posed by medications purchased through illegal sources online.
ASOP Global Applauds Reintroduction of Bipartisan SHOP SAFE Act
October 3, 2023
The SHOP SAFE Act incentivizes online marketplaces to engage in best practices and combat widespread fraud and illegal activity on their platforms.
September 6, 2023
Through advocacy, education, and policy, the Alliance for Safe Online Pharmacies (ASOP Global) works to disrupt illegal online drug sellers’ schemes and has submitted comments to the United States Patent and Trademark Office (USPTO) outlining challenges and solutions to achieve that mission.
August 22, 2023
ASOP Global participated in “Counterfeit Drugs in the Community,” a roundtable discussion in Los Angeles, CA, hosted by the International Trademark Association (INTA).
ASOP Global Welcomes New Members IQVIA and Translucent Datalab
August 9, 2023
Data Solutions Giants Join ASOP Global to Protect Patients from Illegal Online Drug Sellers
July 13, 2023
The U.S. Senate Judiciary Committee held a markup of S.1080, the Cooper Davis Act. The Alliance for Safe Online Pharmacies (ASOP Global) applauds the Senate Judiciary Committee for pushing Big Tech to take a more proactive role against illegal online drug sellers.
ASOP Global Participates in Fourth FDA Summit
June 22, 2023
ASOP Global participated in the Federal Drug Administration’s fourth Online Controlled Substances Summit. This year, the FDA broadened its focus from opioids to all controlled substances. As part of the summit’s expanded scope, the Center for Drug Evaluation and Research, the United Nations’ Global OPIOIDS Project, U.S. Customs and Border Protection, and other experts examined global trends and policy and law enforcement solutions for stopping the illegal online sale of opioids and other controlled substances.
ASOP Global Names Former U.S. Official Susan Wilson to Its Board of Directors
May 25, 2023
ASOP Global has named Susan Wilson to its Board of Directors. For more than 30 years, Susan served in technical and leadership positions at the Department of Commerce’s U.S. Patent & Trademark Office and International Trade Administration, the Office of the United States Trade Representative (USTR), the Departments of State and Justice, and the U.S. Customs Service. She is currently a director of intellectual property policy at Intel Corporation.
Cooper Davis Act Protects America’s Youth Against Deadly Fentanyl-Laced Fake Meds Sold Online
April 24, 2023
The Alliance for Safe Online Pharmacies supports the bipartisan Cooper Davis Act as an important weapon to help federal, state, and local law enforcement fight the illegal online sale of counterfeit medicine laced with potentially deadly doses of fentanyl.
April 19, 2023
Judge Karas’ dismissal of PharmacyChecker.com’s baseless lawsuit confirms what ASOP Global has known from the start: “PharmacyChecker.com makes most of its money by helping people illegally import drugs.”
ASOP Global Statement on Texas Court Decision Revoking FDA Approval of Mifepristone
April 11, 2023
Judge Matthew J. Kacsmaryk’s decision to revoke U.S. Food and Drug Administration (FDA) approval for mifepristone undermines nearly 120 years of FDA legal authority and threatens the health and safety of American women.
ASOP Global Urges DEA to Consider Risks to Patient Safety in Proposed Rule
March 31, 2023
Telemedicine Prescribing Rule Likely to Drive Unsuspecting Consumers to Illegal Online Pharmacies
New Public Service Campaign to Safeguard Online Consumers Launches
December 14, 2022
Actor Danny Trejo in action warning consumers about #BadMeds and to verify before they buy.
ASOP Global Applauds House Passage of the INFORM Consumers Act
November 17, 2022
ASOP commends the U.S. House of Representatives for passing H.R. 5502, the Integrity, Notification, and Fairness in Online Retail Marketplaces (INFORM) for Consumers Act. The bipartisan bill requires online marketplaces to verify high-volume sellers and provide consumers with their contact information. The legislation also enables law enforcement to prosecute criminals and remove counterfeit, dangerous, or defective products from online marketplaces.
October 14, 2022
A new report by The National Association of Boards of Pharmacy (NABP), sponsored by ASOP Global Foundation, shows that locking and suspending websites that illegally sell prescription medications online directly impacts patient safety.
Kellie Barr Selected to Serve as a United States Magistrate Judge
August 8, 2022
The Alliance for Safe Online Pharmacies (ASOP) and the ASOP Global Foundation congratulate Kellie M. Barr on being selected to serve as a United States Magistrate Judge.
Alliance for Safe Online Pharmacy in the EU (ASOP EU) announces new Director
July 22, 2022
ASOP EU is delighted to announce that Stefan Feltens, the President of the European Association of E-Pharmacies (EAEP) will become a Director of ASOP EU, adding significant influence to this important patient safety initiative.
Moderna Joins ASOP Global as Newest Member
June 23, 2022
The Alliance for Safe Online Pharmacies (ASOP Global) welcomed pioneering global pharmaceutical company Moderna as a new member organization today, expanding the company’s long-standing leadership on patient safety issues.
June 9, 2022
The Alliance for Safe Online Pharmacies (ASOP) is thrilled to congratulate President of the Board of Directors, John Hertig, PharmD, MS, FASHP, and Board Member Ilisa Bernstein on their recent promotions. Hertig has been named Chair of Pharmacy Practice in Butler University’s College of Pharmacy and Health Sciences (COPHS). Bernstein, PharmD, JD, FAPhA, has been named Interim CEO of the American Pharmacists Association (APhA).
January 28, 2022
The Alliance for Safe Online Pharmacies (ASOP Global) is encouraged to see the inclusion of critical consumer health and safety protections in the America Competes in Manufacturing, Pre-Eminence in Technology, and Economic Strength Act (America COMPETES Act) introduced in the House this week.
ASOP Global Endorses Bipartisan, Bicameral DRUGS Act
January 5, 2022
The Alliance for Safe Online Pharmacies (ASOP Global) applauds Sen. Amy Klobuchar (D-MN), Sen. Marco Rubio (R-FL), Rep. Bobby Rush (D-IL), and Rep. David McKinley (R-WV) for the bicameral introduction of the bipartisan Domain Reform for Unlawful druG Sellers Act (DRUGS Act).
December 21, 2021
The Alliance for Safe Online Pharmacies strongly supports S.3399, the Domain Reform for Unlawful druG Sellers Act (DRUGS Act).
ASOP Global Endorses the Domain Reform for Unlawful druG Sellers (DRUGS) Act
December 16, 2021
The Alliance for Safe Online Pharmacies (ASOP Global) applauds Sens. Marco Rubio (R-FL) and Amy Klobuchar (D-MN) for introducing the bipartisan S.3399 Domain Reform for Unlawful druG Sellers Act (DRUGS Act) yesterday
ASOP Global Applauds Congress for Swift Action on the INFORM Consumers Act
November 17, 2021
ASOP Global applauds the U.S. House Energy & Commerce Committee for moving this critical bill swiftly through the legislative process.
October 26, 2021
The Alliance for Safe Online Pharmacies (ASOP Global) applauds the Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Data Security for calling attention to the dangers of deadly drugs easily obtained online.
ASOP Global Urges Swift Passage of the INFORM Consumers Act
October 14, 2021
ASOP Global applauds Congress for moving the INFORM Consumers Act quickly through the legislative process and urges the bill’s swift passage to send a powerful message to online criminals that they can no longer act anonymously and without punishment.
ASOP Global Statement on SHOP SAFE Markup
September 29, 2021
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement regarding the SHOP SAFE Act of 2021 markup.
ASOP Global Condemns Websites Falsely Marketing Ivermectin as a COVID Cure
September 15, 2021
ASOP Global joins members of the American Pharmacists Association (APhA) and American Society of Health-System Pharmacists (ASHP), along with the American Medical Association (AMA), in warning against the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial.
ASOP Global Participates in Third FDA Online Opioid Summit
September 9, 2021
The Alliance for Safe Online Pharmacies (ASOP Global) will participate in the third U.S. Food and Drug Administration (FDA) Online Opioid Summit. The Summit provides a critical forum for experts from academia, government, private, and nonprofit sectors to collaborate on ways to detect and reduce the availability of opioids on the internet.
July 18, 2021
The Alliance for Safe Online Pharmacies in the EU (ASOP EU), along with six health-centered organizations, co-signed a letter to members of the European Parliament and the European Council requesting the expansion of the proposed Digital Services Act (DSA) to include online intermediaries.
July 12, 2021
According to a new national survey the ASOP Global Foundation commissioned from Abacus Data, nearly half of American consumers are willing to risk threats to their health by purchasing medications from unregulated online sources for the sake of more convenience and lower prices. Further, U.S drug importation policies give consumers a false sense of security, leading many to misbelieve that all Canadian medicines sold online are safe and legitimate. Alarmingly, more than one-third of consumers polled say they would knowingly ignore explicit government prohibitions from buying medicines from Canadian online pharmacies because of their misperceptions that they can safely access cheaper medications from sources abroad.
ASOP Global Opposes New Biden Policy on Canadian Drug Importation.
July 12, 2021
Friday, President Biden issued an Executive Order that directs the Food and Drug Administration (FDA) to work with states and tribes on plans to import prescription drugs from Canada. In response, Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Global Applauds HHS Reversal of the Trump Administration’s Drug Importation Scheme
July 8, 2021
The Alliance for Safe Online Pharmacies issued the following statement in response to the Department of Health and Human Services announcement that it will revoke a Trump-era call for proposals to create pathways for personal prescription drug and insulin importation from other countries.
ASOP EU Gains Official Observer Status at the Medicrime Convention Committee of the Parties
May 26, 2021
The Alliance for Safe Online Pharmacy in the EU (ASOP EU) has joined the Medicrime Committee of the Parties (CoP) as an Observer.
ASOP Global Expresses Support for SHOP SAFE Act
May 26, 2021
The Alliance for Safe Online Pharmacies issued the following statement in support of the “Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce Act” (SHOP SAFE Act) and this week’s congressional hearing on the legislation.
ASOP Global Endorses INFORM Consumers Act
May 25, 2021
the Alliance for Safe Online Pharmacies issued the following statement in support of the bipartisan Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers Act (INFORM Consumers Act).
April 7, 2021
The European Alliance for Access to Safe Medicines (EAASM) has published its report ‘Patient Safety and the Implementation of the Falsified Medicines Directive in the Hospital Environment: Practical solutions and benefits’. Read the full release here.
ASOP Global Statement on Congressional Hearing with CEOs of Facebook, Twitter, and Google
March 26, 2021
The Alliance for Safe Online Pharmacies issued the following statement about yesterday’s joint hearing on disinformation and the role of social media before the Subcommittee on Communications and Technology and the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce.
ASOP Global Welcomes Opportunity to Work with HHS Secretary Becerra
March 18, 2021
Today, the Alliance for Safe Online Pharmacies issued the following statement in response to the United States Senate’s confirmation of Department of Health and Human Services Secretary Xavier Becerra.
ASOP Global Applauds the Reintroduction of the PACT Act
March 17, 2021
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in support of the recently reintroduced Platform Accountability and Consumer Transparency Act (PACT Act).
Novartis Joins ASOP Global as Newest Member
February 2, 2021
The Alliance for Safe Online Pharmacies is proud to welcome global health care company Novartis as a new member organization.
ASOP Global Reaffirms Support for Targeted Section 230 Reform Bill
February 1, 2021
The Alliance for Safe Online Pharmacies issued the following statement in response to the reintroduction of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX).
ASOP Global Applauds NTIA for Urging Congress to Protect Americans Online
January 6, 2021
As a member of the Coalition for a Secure and Transparent Internet (CSTI), the Alliance for Safe Online Pharmacies (ASOP Global) signed recent letters applauding the National Telecommunications and Information Administration (NTIA) for calling on the House and Senate to address open access to accurate WHOIS data.
ASOP Global Commends U.S. Attorney Hur for Fighting Against COVID-19 Fraud
December 21, 2020
In response to the recent seizure by the U.S. Attorney’s Office for the District of Maryland of websites for fraudulently posing as legitimate biotechnology companies actively developing treatments for COVID-19, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Global Urges Consumers to Remain Aware of COVID-19 Fraud
December 11, 2020
In response to the anticipated emergency use authorizations (EUAs) for several COVID-19 vaccines and availability of a direct-to-consumer COVID-19 test system, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Canada Statement on Health Canada Interim Order to Prevent Diversion of Canada’s Drug Supply
November 30, 2020
In response to Health Canada’s release of an Interim Order (IO) to prevent the diversion of Health Canada-approved medicines, ASOP Canada issued the following statement.
ASOP Global Statement of Opposition to Drug Importation Rule
November 30, 2020
In response to the U.S. Food and Drug Administration’s (FDA) Importation of Prescription Drugs Final Rule taking effect today, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement of opposition.
ASOP Global Statement On Launch Of Amazon Pharmacy
November 17, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to the launch today of Amazon Pharmacy.
New Survey Reveals Dangerous Disconnect in American Perceptions of Online Pharmacies
October 19, 2020
According to a new national survey the Alliance for Safe Online Pharmacies (ASOP Global) commissioned from Abacus Data, the COVID-19 pandemic is accelerating an already growing trend toward the digitalization of the healthcare industry, including increased utilization of telemedicine and the purchase of medications online.
ASOP Global Statement on New Section 230 Reform Bill
September 29, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to the introduction today of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX).
ASOP Global Statement on the Publication of FDA’s Final Rule on Drug Importation
September 25, 2020
In response to yesterday’s publication of the U.S. Food and Drug Administration’s (FDA) Final Rule on Drug Importation, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Canada Statement on U.S. Final Rule to Import Prescription Medicines from Canada
September 25, 2020
In response to yesterday’s announcement by the Trump Administration and final regulations to allow importation of prescription medicines, ASOP Canada issued the following statement.
ASOP Global Statement on FDA Crackdown on Website Operators Illegally Selling Opioids
September 10, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to warning letters issued by the U.S. Food and Drug Administration to 17 website operators advertising and selling illegal, unapproved and misbranded opioids online.
ASOP Global Statement on President Trump’s Executive Order on Accelerated Timeline for State Drug Importation Proposals
July 27, 2020
In response to the Executive Order President Trump signed Friday to set price controls on drugs imported from other countries into the U.S., the Alliance for Safe Online Pharmacies (ASOP Global), issued the following statement.
ASOP Global Applauds the Introduction of the Platform Accountability and Consumer Transparency Act
June 24, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to today’s announcement by Senate Commerce, Science, Transportation Subcommittee on Communications, Technology, Innovation and the Internet Chairman John Thune (R-SD) and Ranking Member Brian Schatz (D-HI) regarding the introduction of the Platform Accountability and Consumer Transparency Act (PACT Act).
Canadians are more open to ordering medication and medical supplies online amid the COVID-19 pandemic
June 18, 2020
A new comprehensive survey released today from the Alliance for Safe Online Pharmacies Canada (ASOP Canada) revealed that since the COVID-19 pandemic began, half of Canadians have become more open to ordering medication, medical supplies or other healthcare products online.
Youth IGF Movement Form An Alliance With 3 French Healthcare Companies And ASOP EU Launching A Global Education Programme To Combat COVID-19 Scams And Fake Medicines
June 10, 2020
The Youth IGF Movement, created by Yuliya Morenets, has teamed up with the Alliance for Safe Online Pharmacy in the EU (ASOP EU) supported by three French global healthcare companies Ipsen, Sanofi and Servier to educate the youth about buying fake medicines online in particular COVID-19 scams. The campaign is called “We rely on you. We rely on youth”.
ASOP Global Statement on FDA/NTIA Pilot Program to Stop Illegal Online Opioid Sales
June 9, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to yesterday’s joint announcement by the U.S. Food and Drug Administration (FDA) and the National Telecommunications and Information Administration (NTIA) of a new pilot program to help stop the illegal sale of opioids online.
ASOP Global Commends USTR for Identifying Bad Actors in Domain Name Industry
May 5, 2020
In response to the release of the Office of the United States Trade Representative’s (USTR) annual Special 301 Report on Intellectual Property Protection and Review of Notorious Markets for Counterfeiting and Piracy, ASOP Global issued the following statement.
43 Stakeholders Have Now Joined ASOP Global’s Call for the Administration to Take Action to Protect Consumers from Online COVID-19 Scams and Misinformation
April 21, 2020
More than 40 public health, trade association, industry, and research groups, including the National Consumers League (NCL) and the Coalition for a Secure and Transparent Internet (CSTI), have now joined the Alliance for Safe Online Pharmacies (ASOP Global) in urging Vice President Mike Pence, members of the White House Coronavirus Task Force, cabinet officials, and other state and national leaders to take further action to protect consumers from online COVID-19 scams and misinformation.
ASOP Global Statement on Senators’ Call for Domain Industry Accountability to Combat COVID-19 Misinformation and Fraud
April 15, 2020
In response to letters sent by Senators Mazie Hirono (D-Hawaii), Cory Booker (D-N.J.) and Maggie Hassan (D-N.H.) calling on domain name registrars and hosts to fight scams and misinformation during the COVID-19 crisis, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement today.
ASOP Global Urges Administration to Act Now to Protect Consumers from Online COVID-19 Scams and Misinformation
April 9, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) and more than 30 other public health, trade association, industry, and research groups, including the National Consumers League (NCL) and the Coalition for a Secure and Transparent Internet (CSTI), sent a joint letter today to Vice President Mike Pence, members of the White House Coronavirus Task Force, cabinet officials, and other state and national leaders urging them to take further action to protect consumers from online COVID-19 scams and misinformation.
In response to the newly released report by the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD) entitled “Illicit Trade in Counterfeit Pharmaceutical Products,” the Alliance for Safe Online Pharmacy in the EU (ASOP EU) applauds the research conducted to better highlight and quantify the pervasive threat of illegal online drug sellers.
ASOP Global Statement on EUIPO and OECD Counterfeit Pharmaceuticals Trade Report
March 23, 2020
In response to a new report released by the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD) on fake medicines and the global illicit trade in counterfeit pharmaceuticals, the Alliance for Safe Online Pharmacies (ASOP Global), issued the following statement
ASOP Global Statement on Fake COVID-19 Claims Online
March 20, 2020
In response to widespread misinformation about COVID-19 online, the Alliance for Safe Online Pharmacies (ASOP Global), issued the following statement today.
ASOP Global Names ASHP’s Schulte Wall to Board of Directors
March 5, 2020
The Alliance for Safe Online Pharmacies (ASOP Global) has named Jillanne Schulte Wall, J.D. to its board of directors.
ASOP Global Names New Board of Director Members
January 24, 2020
ASOP Global has named three new members to its board of directors, including former U.S. Food and Drug Administration compliance and policy official Dr. Ilisa Bernstein.